Search Results (351)

Background: This case report presents a 12-year-old male with vertically transmitted chronic hepatitis B virus (HBV) infection, exhibiting a rare pan-reactive serological profile (concurrent HBsAg, HBsAb, HBeAg, HBeAb, and HBcAb positivity) alongside fluctuating low-level viremia (HBV DNA: 1.06 × 10² IU/mL to undetectable). Rigorous exclusion of technical artifacts confirmed the authenticity of this atypical serologic pattern, observed in <0.001% of the general population. Methods: Liver biopsy and immunohistochemical staining were performed to evaluate hepatic inflammation and fibrosis. HBV serological markers and viral load were quantified using commercial diagnostic kits, with longitudinal monitoring for 18 months. Results: Liver biopsy revealed Grade 2 inflammation with focal HBsAg/HBcAg expression, supporting immune-active chronic hepatitis B (CHB) despite partial seroconversion. The patient’s clinical course highlights key challenges in pediatric HBV management: (1) delayed immune reconstitution (18-month longitudinal HBeAg/HBeAb dynamics), (2) non-linear virologic-ALT correlation, and (3) diagnostic ambiguity in pan-positive serology—potentially reflecting S-gene escape mutants or transitional immune responses. Initiation of tenofovir disoproxil fumarate (TDF) achieved sustained virologic suppression, underscoring the importance of early antiviral therapy in pediatric CHB with atypical markers. Conclusions: This case provides preliminary insights into the complex interplay between viral evolution and immature host immunity, advocating for refined monitoring protocols integrating high-sensitivity HBV DNA, quantitative serology, and non-invasive fibrosis assessment in pediatric HBV care. Full article

The emergence of variant strains of Avian orthoreovirus (ARV) has caused substantial economic losses in the poultry industry worldwide, but the molecular features of goose-origin strains and viral transmission among different avian species remain poorly understood. Here, we describe a goose-origin avian orthoreovirus strain, SD0407, associated with growth retardation and joint swelling. Complete genome analysis identified ten double-stranded RNA segments. Sequence comparison indicated that SD0407 is closely related to previously reported duck-origin reovirus strains. Phylogenetic and recombination analyses showed that most segments clustered with duck-origin strains, indicating close genetic relatedness among waterfowl-origin orthoreoviruses. Sequence and structural analysis of the σC attachment protein revealed ten unique amino acid substitutions, including D250 within the DE-loop region involved in receptor-binding. Molecular docking suggested that σC interacts with the conserved AnxA2-S100A10 heterotetrameric receptor complex, providing a possible structural basis for receptor compatibility across avian species. Although SD0407 replicated efficiently in goose embryo fibroblasts, it did not induce expression of type I, II or III interferons. Transcriptome profiling revealed weak activation of innate immune signaling and downregulation of metabolic and cytoskeletal genes, consistent with effective suppression of antiviral responses. These findings demonstrate that SD0407 combines structural variability with immune evasion to enhance host adaptability and underscore the importance of sustained ARV surveillance in waterfowl populations. Full article

The complement system is a key component of innate immunity, known primarily as an immune surveillance mechanism. However, it is also widely known as a modulator of immune responses and inflammation, and its activation has been reported in a wide array of conditions that can lead to admission to the intensive care unit (ICU). Furthermore, various ICU monitoring practices and treatment interventions of the ICU needed to sustain vital organ function may disrupt complement homeostasis. In this review, we will describe in detail the role of the complement system in various critical care settings, with emphasis on major ICU-related conditions such as bacterial and viral sepsis, trauma and burn. Additionally, we will address the potential value of this complex cascade as a prognosis tool and the possible implications for clinical practice as well as its potential as a target for future innovative therapeutic strategies. Full article

Peste des Petits Ruminants (PPR), a highly contagious disease of domestic and wild small ruminants, is characterized by severe morbidity and mortality. PPRV, the causative agent, is a morbillivirus in the family Paramyxoviridae. The virus poses a significant barrier to sustainable agricultural development in the developing world. Currently, no effective therapeutics agent for PPRV infection is available. Ginsenoside Rb3, the major bioactive constituent in the plants of ginseng, was reported to exert a wide range of pharmacologic and immunologic effects. However, it is unclear whether Ginsenoside Rb3 can act as an antiviral against PPRV infection. Here, we show that Ginsenoside Rb3 exhibits significant antiviral activity against PPRV in cell culture models. The mechanism of action of Ginsenoside Rb3 against PPRV is mainly attributed to its ability to inhibit PPRV-mediated autophagy, thus leading to promotion of interferon responses. In summary, our study establishes Ginsenoside Rb3 as a novel antiviral agent effective against PPRV, sheds light on its mode of action, and reveals a novel immunomodulatory strategy that may prove essential for combating both current and future viral outbreaks. Full article

Crop fungal and viral diseases cause annual economic losses exceeding USD 150 billion globally, demanding rapid, sensitive, and field-deployable diagnostic technologies. This review critically evaluates recent advances in electrochemical biosensing platforms for early crop pathogen detection, focusing on immunosensors, genosensors, aptasensors, and VOC-based systems. Reported analytical performances demonstrate ultralow detection capabilities, including 0.3 fg mL⁻¹ for viral coat proteins, 15 DNA copies for bacterial pathogens, 0.5 fg µL⁻¹ RNA detection for viroids, and nanomolar-level VOC sensing (35–62 nM), with response times ranging from 2 to 60 min. Comparative analysis reveals that genosensors and aptasensors generally achieve the lowest LODs due to nucleic acid amplification or high-affinity recognition, while immunosensors provide robust protein-level specificity validated against ELISA. Volatile organic compound (VOC) sensors enable non-invasive, pre-symptomatic monitoring but face specificity challenges. Despite strong laboratory performance, practical adoption is limited by matrix-derived electrochemical interference, environmental instability of biorecognition elements, workflow complexity, and insufficient standardization across studies. Emerging innovations, including magnetic bead enrichment, nanoporous and graphene-based electrodes, microfluidic integration, AI-assisted impedance interpretation, and biodegradable substrates, are progressively addressing these bottlenecks. This review emphasizes that successful field translation requires holistic workflow engineering, matrix-matched validation, and harmonized performance metrics rather than incremental sensitivity improvements alone. By integrating analytical chemistry, nanomaterials engineering, and agricultural decision-support frameworks, electrochemical biosensing platforms hold significant potential to enable decentralized, rapid, and sustainable crop disease management. Full article

Background/Objectives: Eliciting robust immune responses against the hepatitis B virus (HBV) through therapeutic vaccination holds promise for curing chronic hepatitis B. We previously developed the heterologous protein prime/viral vector boost clinical vaccine candidate, TherVacB. Here, we evaluated a replication-competent chimeric vesicular stomatitis virus vector (VSV-GP) as an alternative viral vector boost vaccine. Methods: A recombinant VSV-GP vector co-expressing HBV surface and core antigens (VSV-GP-HBs/c) was generated and characterized for antigen expression. Its immunogenicity, antiviral efficacy, and durability were assessed in HBV-naïve and HBV-carrier mice, using protein primed, viral vector-primed, and multi-viral vector boost regimens. Results: VSV-GP-HBs/c efficiently expressed both HBV antigens in vitro. A single immunization with VSV-GP-HBs/c induced only weak HBV-specific immune responses in vivo. Replacing protein priming with VSV-GP-HBs/c resulted in modest immune activation and limited antiviral effects in HBV-carrier mice. In contrast, substituting the modified vaccinia virus Ankara (MVA)-HBs/c boost in the TherVacB regimen with VSV-GP-HBs/c elicited robust HBV-specific antibody responses and strong CD4 and CD8 T-cell immunity, assessed by intracellular IFN-γ staining after peptide stimulation. This regimen achieved a substantial reduction in serum HBsAg levels, numbers of HBV-positive hepatocytes, and intrahepatic HBV-DNA, with antiviral efficacy comparable to that of the classical TherVacB regimen. Notably, a second viral vector boost did not enhance HBV-specific immunity or antiviral efficacy; instead, it promoted dominant vector-specific CD8 T-cell responses. Long-term analyses performed 10 weeks after the last vaccination further demonstrated that a single protein-prime/VSV-GP-HBs/c boost was sufficient to achieve sustained antiviral control. Conclusions: These findings identify VSV-GP-HBs/c as an effective boost vector for therapeutic hepatitis B vaccination and establish protein priming followed by a single viral vector boost as an optimal strategy for sustained antiviral immunity. Full article

Viral and bacterial pathogen pathogens cause disease outbreaks that challenge the pearl gentian grouper (Epinephelus fuscoguttatus ♀ × E. lanceolatus ♂) industry’s sustainable development. The lack of monoclonal antibodies (mAbs) targeting serum immunoglobulin M (IgM) in this hybrid grouper impedes the development of non-lethal immunoassays for detecting pathogen infections, as well as research on immune responses following vaccination. We purified serum IgM from hybrid pearl gentian grouper and generated two mAbs—designated 41-H2-E1 and 62-E8-G9—against the purified IgM, finding that mAb 62-E8-G9 specifically recognized the IgM heavy chain, whereas mAb 41-H2-E1 specifically recognized the light chain. In indirect immunofluorescence assays, both mAbs reacted with surface Ig-positive (sIg⁺) lymphocytes. A double-antibody sandwich ELISA was subsequently established using mAb 62-E8-G9 as the capture antibody and HRP-conjugated mAb 41-H2-E1 as the detection antibody, enabling accurate quantification of serum IgM levels. Significant differences in IgM concentrations were observed between larger and smaller individuals (9.11 μg/mL vs. 3.84 μg/mL, p < 0.05). In immunostimulant administration experiments, both low-and high-dose groups exhibited approximately 2.0-fold higher IgM levels than the control group (p < 0.05). In contrast, vaccination with inactivated vaccines did not result in statistically significant differences in total IgM levels. mAb 41-H2-E1 was further applied to detect Vibrio parahaemolyticus- and Vibrio harveyi-specific immunoglobulins in serum under different vaccination regimens. Collectively, these findings demonstrated that the mAbs developed in this study served as reliable immunological tools for investigating immune function in hybrid pearl gentian grouper. Full article

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection induces heterogeneous immune responses that influence both acute disease severity and long-term immune remodeling. A key question in the context of infection and vaccination is whether SARS-CoV-2 exerts direct oncogenic effects or instead acts as a transient immunological stressor capable of reinforcing tumor-permissive pathways. Current evidence does not support classical viral oncogenesis. Rather, severe infection is characterized by early interferon (IFN) imbalance followed by NF-κB-dominant inflammatory amplification, promoting sustained IL-6/JAK–STAT3 and MAPK signaling, chronic cytokine production, metabolic reprogramming, and impaired antitumor immune surveillance. At the molecular level, viral structural proteins modulate host signaling networks. The spike (S1) protein engages TLR2/TLR4–MyD88 pathways, activating NF-κB and MAPK cascades, while the membrane (M) protein reinforces NF-κB–STAT3 circuits linked to epithelial–mesenchymal transition and inflammatory gene expression. These mechanisms intensify pre-existing oncogenic signaling without initiating malignant transformation. Tissue-specific responses are further shaped by IFN competence, renin–angiotensin system balance, and metabolic context. In parallel, immune evasion programs shared by chronic viral infection and cancer, including checkpoint upregulation, impaired antigen presentation, and suppressive myeloid expansion, may be transiently reinforced following severe infection. In contrast, SARS-CoV-2 vaccination induces spatially restricted, self-limited innate activation without sustained inflammatory signaling or persistent antigen exposure. By preventing severe disease and chronic immune dysregulation, vaccination interrupts pathways hypothesized to intersect with cancer biology, with no evidence of increased cancer incidence. Ongoing longitudinal studies are required to clarify the long-term oncologic implications of post-infectious immune remodeling. Full article

The soil–water interface (SWI) represents a critical biogeochemical hotspot where steep physicochemical gradients across millimetre-to micrometre-scales create diverse ecological niches controlling nutrient cycling, carbon stabilisation, and contaminant transformation. This review synthesises emerging understanding of micro-scale microbial dynamics, biofilm architecture, and functional processes shaping SWI ecosystems. We examine redox stratification driving microbial community assembly, biofilm-mediated nutrient trapping and soil aggregate stabilisation, and dynamic drivers including hydrological fluctuations, viral lysis, and differential transport at gas–water versus solid–water interfaces. Advanced methodologies, microsensor profiling, cryo-sectioning, spatially resolved metatranscriptomics, and non-destructive imaging, now enable unprecedented resolution of SWI microhabitat chemistry and microbial organisation. Horizontal gene transfer within interface biofilms accelerates adaptive responses to environmental stressors. Integration of micro-scale observations into ecosystem-level models remains challenging but essential for predicting soil carbon sequestration, contaminant fate, and microbial resilience under climate change. Strategic SWI management through biofilm engineering and controlled redox manipulation offers novel pathways for sustainable agriculture and bioremediation, though it requires careful balance of multiple ecosystem functions. Full article

Background: Zika virus (ZIKV) is a mosquito-borne flavivirus associated with severe neurological disease, including congenital Zika syndrome (CZS) following utero infection and Guillain–Barré syndrome in adults. The 2015–2016 epidemic in the Americas highlighted the profound maternal and neonatal consequences of ZIKV infection. Although reported transmission has declined, ongoing circulation of competent vectors and population susceptibility sustain a substantial risk of future outbreaks, underscoring the need for effective vaccines. Methods: We developed a recombinant Modified Vaccinia Ankara (MVA)-based vaccine candidate expressing the ZIKV pre-membrane (prM) and envelope (E) proteins and evaluated its immunogenicity and protective efficacy in interferon receptor-deficient AG129 mice. Results: Vaccination induced strong humoral and cellular immune responses and conferred significant protection against viral replication in key target organs, including the brain and testes, following ZIKV challenge. Conclusions: These preclinical findings support further development of this MVA-based ZIKV vaccine as a promising strategy to prevent ZIKV infection and its associated neurological complications. Full article

Plant defence elicitors have emerged as pivotal components of sustainable fruit crop protection, aligning with One Health principles by reducing chemical residues while enhancing ecosystem and human health. These exogenous agents—ranging from phytohormones, peptides, and cell-wall fragments to botanical extracts—activate or prime innate immune responses in fruit crops through pattern-triggered immunity (PTI), systemic acquired resistance (SAR), and induced systemic resistance (ISR) pathways. Over the last decade, advances in receptor biochemistry, genomics, metabolomics, and epigenetics have transformed this field. Recent mechanistic advances reveal that oligosaccharide elicitors derived from chitosan and laminarin are perceived by membrane-localised pattern recognition receptors (PRRs) that confer broad-spectrum resistance against fungal, bacterial, and viral pathogens in fruits. By contrast, no specific protein receptor has been identified for harpin proteins, the emerging evidence indicating that harpin perception may occur through direct interaction with plasma-membrane lipids or lipid-associated proteins. The One Health approach is supported by elicitors, biodegradability, minimal environmental persistence, and the ability to reduce synthetic fungicide usage by 30–70%. However, challenges remain regarding batch-to-batch variability, sensory acceptance due to bitter compounds, regulatory hurdles for novel food approvals, and the need for optimised application protocols that consider the fruit genotype and developmental stage. The future integration of nanotechnology for targeted delivery, the artificial-intelligence-driven screening of active molecules, and synergistic combinations with biocontrol agents promises to overcome these limitations, positioning plant defence elicitors as cornerstone tools for resilient, health-promoting fruit production systems. Full article

Herpes simplex virus type 1 (HSV-1) is a neurotropic alphaherpesvirus that interacts dynamically with host cells within structured tissue environments. Conventional two-dimensional (2D) cultures do not fully recapitulate these spatial and microenvironmental features. In this study, we established a three-dimensional (3D) culture system using the self-assembling peptide RADA16-I to generate an extracellular matrix–mimetic hydrogel scaffold. This platform supported the formation of stable Vero cell spheroids that remained viable for more than 30 days. Following HSV-1 infection, viral spread initiated at the spheroid periphery and progressively extended toward the core. Sustained viral replication was detected for up to 22 days, indicating long-term maintenance of infection within the 3D structure. Ultrastructural examination identified viral particles and vesicular compartments consistent with autophagy-related organelles. Comparative analysis of autophagy-associated markers revealed distinct temporal patterns between 2D monolayer cultures and 3D spheroids. In the 3D system, LC3B-II levels progressively increased, accompanied by a reduction in p62, suggesting altered regulation of autophagic flux relative to conventional 2D conditions. These findings demonstrate that the RADA16-I-based 3D culture model supports prolonged HSV-1 infection and reproduces key spatial features of viral dissemination. The differential autophagic responses observed between 2D and 3D systems highlight the influence of cellular architecture on host–virus interactions and support the application of 3D culture platforms for mechanistic studies of HSV-1 pathogenesis. Full article

Acute respiratory infections (ARIs) remain a common cause of morbidity and mortality in children, especially in sub-Saharan Africa, where countries such as Ghana are severely affected. This review presents recent data on ARI etiology, clinical burden, and antimicrobial resistance (AMR) from Ghana, spanning the pre-COVID-19 era (2010–2019) to the post-pandemic period (2020–2025). Before the COVID-19 pandemic, viral infections, such as respiratory syncytial virus (RSV), rhinoviruses, and influenza viruses, were the major contributors, along with established bacterial pathogens such as Streptococcus pneumoniae and Haemophilus influenzae. Social determinants, including undernutrition and indoor air pollution, also influenced these infections. In the COVID era, we have seen dramatic shifts in pathogen seasonality, the scaling of oxygen delivery systems, and the implementation of genomic surveillance for SARS-CoV-2, as well as new features such as maternal RSV vaccination and monoclonal antibody therapy. Despite its successes in vaccination coverage and health system strengthening, some challenges remain, including fluctuations in implementation and surveillance issues. The simultaneous challenges of pneumonia and hygiene will require integrated, coordinated, multisectoral responses that incorporate surveillance with antibiotic stewardship, sustainable oxygen systems, and interventions for nutrition and environmental health. The review also highlights research priorities and makes policy recommendations well aligned to support national ARI control efforts aimed at reducing child mortality due to ARI and achieving Sustainable Development Goals targets on child health. Full article

Alfalfa mosaic virus (AMV) is a devastating plant pathogen with an extensive host range, yet effective control strategies remain limited. This study investigated the prophylactic efficacy and molecular mechanisms of two plant immune inducers, the Paecilomyces variotii extract DYDS and the antiviral agent Dufulin, against AMV infection in cowpea (Vigna unguiculata). Our results demonstrate that both agents possess potent antiviral activity, with inactivation, protective, and therapeutic efficacies all exceeding 21.00%. Notably, DYDS exhibited superior overall performance. RT-qPCR and immunofluorescence assays confirmed a significant downregulation of AMV coat protein (CP) expression in treated plants. Furthermore, exogenous application of these inducers mitigated chlorophyll loss and markedly augmented the activities of key defense enzymes’ activity, including superoxide dismutase (SOD), peroxidase (POD), catalase (CAT), polyphenol oxidase (PPO), and L-phenylalanine ammonia-lyase (PAL), peaking at 5 days post-inoculation. In silico molecular docking simulations further revealed that DYDS and Dufulin interact spontaneously with the AMV-CP, yielding binding free energies of −6.5 and −5.8 kcal/mol, respectively. Gene expression analysis indicated that these inducers trigger a robust immune response through the integrated activation of the salicylic acid (SA), jasmonic acid (JA), and ethylene (ET) signaling pathways. Collectively, these findings suggest that DYDS and Dufulin provide a dual mode of action—direct viral inhibition and host immune priming—offering a promising and sustainable approach for the management of AMV in leguminous crops. Full article

Viral diseases pose a major threat to tomato cultivation, mainly due to the lack of effective antiviral control methods. Plant growth-promoting microorganisms (PGPMs) represent a promising and sustainable strategy for virus disease management, as, in addition to plant growth, they can promote resistance to pathogens. In this study, we examined the antiviral potential of selected PGPMs against three economically important and genetically distinct tomato viruses, tomato spotted wilt virus (TSWV, Orthotospovirus tomatomaculae), cucumber mosaic virus (CMV, Cucumovirus CMV), and tomato brown rugose fruit virus (ToBRFV, Tobamovirus fructirugosum) under controlled greenhouse conditions. The efficacy of each PGPM was assessed by monitoring disease development via visual scoring and DAS-ELISA. Our results indicate a significant TSWV symptom attenuation upon the application of Paraburkholderia eburnea EP3 and the yeast isolate SRL248, though, without a respective reduction in virus accumulation. However, no antiviral effect was observed by any PGPM tested against CMV or ToBRFV. A targeted gene expression analysis revealed a PGPM-specific induction of salicylic acid-dependent defense and RNA silencing markers, indicating priming of host immune responses. Overall, this work increases our knowledge on the antiviral potential of PGPMs showing a strain- and virus-specific effect primarily associated with enhanced symptom tolerance. Full article